{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Mapreg", "item": "https://www.patentleaderboard.com/2021/company/mapreg"}, {"@type": "ListItem", "position": 4, "name": "Etienne Baulieu", "item": "https://www.patentleaderboard.com/2021/inventor/fl:et_ln:baulieu-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
EB

Etienne Baulieu — 1 Patent in 2021

MAMapreg: 1 patents #1 of 5Top 20%
Le Kremlin-Bicêtre, FR: #3 of 12 inventorsTop 25%
Overall (2021): #461,066 of 548,734Top 85%
1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDate
11077122 Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of substance use disorders George F. Koob, Barbara JEAN MASON, Olivier GEORGE, Isabelle VILLEY 2021-08-03